We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$893M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
251
American Tower
AMT
$79.8B
$14M 0.09%
155,582
+6,121
+4% +$530K
KMI icon
252
Kinder Morgan
KMI
$69.7B
$13.9M 0.09%
383,397
+7,223
+2% +$244K
BHP icon
253
BHP
BHP
$223B
$13.6M 0.08%
234,748
+13,348
+6% +$784K
DVA icon
254
DaVita
DVA
$11.5B
$13.6M 0.08%
187,732
-2,913
-2% -$203K
CA
255
DELISTED
CA, Inc.
CA
$13.6M 0.08%
472,390
+31,056
+7% +$919K
MUB icon
256
iShares National Muni Bond ETF
MUB
$45.3B
$13.6M 0.08%
124,911
+15,663
+14% +$1.69M
DBEF icon
257
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.33B
$13.5M 0.08%
490,898
+267,177
+119% +$7.37M
RJF icon
258
Raymond James Financial
RJF
$34.4B
$13.5M 0.08%
400,283
+15,075
+4% +$503K
VRTX icon
259
Vertex Pharmaceuticals
VRTX
$123B
$13.5M 0.08%
142,426
+22,716
+19% +$1.59M
GEO icon
260
The GEO Group
GEO
$4.03B
$13.5M 0.08%
565,487
-36,814
-6% -$829K
BND icon
261
Vanguard Total Bond Market
BND
$157B
$13.4M 0.08%
163,446
+6,502
+4% +$531K
MET icon
262
MetLife
MET
$64.3B
$13.4M 0.08%
271,150
-27,266
-9% -$1.28M
DXJ icon
263
WisdomTree Japan Hedged Equity Fund
DXJ
$7.35B
$13.4M 0.08%
271,538
+7,775
+3% +$368K
PNR icon
264
Pentair
PNR
$11.2B
$13.4M 0.08%
275,773
-6,769
-2% -$344K
FWONA icon
265
Liberty Media Series A
FWONA
$22.9B
$13.3M 0.08%
549,410
+98,715
+22% +$2.26M
BUD icon
266
AB InBev
BUD
$165B
$13.3M 0.08%
115,808
+10,128
+10% +$1.11M
LQD icon
267
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$13.3M 0.08%
111,142
+11,670
+12% +$1.38M
VIG icon
268
Vanguard Dividend Appreciation ETF
VIG
$114B
$13.3M 0.08%
170,027
+3,888
+2% +$297K
LOW icon
269
Lowe's Companies
LOW
$122B
$13.2M 0.08%
274,712
+24,072
+10% +$1.12M
STJ
270
DELISTED
St Jude Medical
STJ
$13.2M 0.08%
189,982
+6,518
+4% +$423K
ADSK icon
271
Autodesk
ADSK
$51.2B
$13M 0.08%
229,734
+27,919
+14% +$1.42M
WBK
272
DELISTED
Westpac Banking Corporation
WBK
$12.9M 0.08%
402,843
+46,764
+13% +$1.51M
KOG
273
DELISTED
KODIAK OIL & GAS CORP
KOG
$12.9M 0.08%
884,305
-11,181
-1% -$145K
MRSH
274
Marsh
MRSH
$92.2B
$12.9M 0.08%
248,253
+14,367
+6% +$714K
BR icon
275
Broadridge
BR
$18.8B
$12.9M 0.08%
308,819
-16,913
-5% -$662K

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $893M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.